echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > [News] SARS-CoV-2 genome reveals the dynamics of the surge of alpha and beta variants in the UK

    [News] SARS-CoV-2 genome reveals the dynamics of the surge of alpha and beta variants in the UK

    • Last Update: 2021-11-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    This article is original by Translational Medicine.
    Please indicate the source for reprinting.
    Author: Joe Guide: Recently, the genome dynamic monitoring data of Alpha and Delta variants in the United Kingdom were published in the journal Nature.
    The researchers came from the European Molecular Biology Laboratory European Biology Information Research Institute (EMBL-EBI) and Wellcome Sanger Research Institute
    .

    At the same time, the research aims to monitor Alpha, Delta variants and other versions of mutated viruses to deal with uncertain future trends of the epidemic
    .

    According to the latest research on the SARS-CoV-2 genome of the COVID-19 Genomics UK Consortium (COG-UK), the UK's COVID-19 has experienced multiple epidemics and sub-epidemics caused by different SARS-CoV-2 strains Sick
    .

    Jeffrey Barrett, head of the COVID Genomics Initiative and co-senior and co-corresponding author of the Wellcome Sanger Institute’s COVID Genomics Initiative, said in a statement, “These genomic monitoring data provide us with a new way to observe the development of the epidemic.
    It gives us a lot of knowledge about how new infectious pathogens spread and evolve
    .

    " Jeffrey Barrett said: "My hope is that similar genome monitoring projects will be developed all over the world, so that we can do as well as possible.
    Prepare for future outbreaks of infectious diseases-whether it is a familiar pathogen or a new pathogen
    .

    "As they reported in the journal Nature on Thursday, the researchers came from the European Molecular Biology Laboratory, the European Institute for Bioinformatics (EMBL-EBI), and the Wellcome Sanger Institute
    .

    From early September 2020 to the end of June 2021 Researchers collected nearly 281,200 SARS-CoV-2 isolates from 315 local health authorities in England and analyzed their genome sequences using systematic geographic analysis and other methods
    .
    The
    research team explained that the sequenced virus specimens It accounts for more than 7% of the number of PCR-positive samples identified in this time frame, spanning approximately 71 virus lineages, and its prevalence is constantly changing over time
    .

    Through the analysis of the SARS-CoV-2 genome related to the geographical area , Researchers can trace the influx, spread, and interactions between new strains in different regions of the country
    .

    Moritz Gerstung, a joint senior researcher and corresponding author of EMBL-EBI and the German Cancer Research Center, said in a statement: “We can see The side-by-side pedigrees, and mapping to specific locations, are incredibly informative in understanding how this series of epidemics unfolded
    .

    "The authors also pointed out that during the broader COVID-19 pandemic, the COG-UK team has sequenced nearly 600,000 SARS-CoV-2 isolates
    .

    They explained: "At the same time, under the same restrictions.
    Next, among comparable populations, our intensive genome surveillance analysis identified a lineage that has consistently grown faster than others in each local health authority
    .

    "For example, when the autumn of 2020 gradually enters the winter, the researchers found that the so-called Alpha variant of SARS-CoV-2 has increased in representativeness, and this variant appears to be more representative than the previously widely circulated lineage.
    Communicative
    .

    Despite the introduction of epidemic restrictions later in 2020, the Alpha mutant strain continues to spread, and the virus strain seems to have been suppressed in another stricter national "blockade" in early 2021
    .

    Where Alpha variants and other leading lineages were found to cause the epidemic to lock down, other versions of the virus began to evolve forward, usually those mutations that changed the SARS-CoV-2 spike protein
    .

    At the same time, these were largely replaced by a "Delta" SARS-CoV-2 variant, which gained a foothold and began to dominate with the relaxation of epidemic restrictions
    .

    By the end of June, "Delta" accounted for approximately 98% of the SARS-CoV-2 variants detected in the region
    .

    "These data show that in the fall of 2020, as Alpha and Delta variants sweep across the mainland of England, the strains show diversity," the author report said.
    "Variants with fairly high heritability have the strongest positive selection.
    It also swept England during the 10-month period of this investigation
    .

    ” The team pointed out that more monitoring and analysis are needed to maintain the label of other versions of the mutant virus in the human host population and adapt to the ever-increasing immunity.
    Rate
    .

    "Thanks to the genomic monitoring conducted in the UK and internationally, it is clear that the virus we are dealing with has changed a lot since we detected a variant in March 2020," the UK Health and Security Agency's COVID-19 Event director and co-author Meera Chand said in a statement, "We will continue to monitor the SARS-CoV-2 virus to ensure that we can use the most effective vaccines, therapeutic drugs and public health measures to combat current and future SARS.
    -CoV-2 variants
    .

    "The 3rd Shanghai International Cancer Conference [Live] Opportunities and Challenges for Standardization of TMB Testing Hot Articles New Crown Epidemic [Cell Sub-Journal] Under COVID-19, are the stem cell therapies that are competing to develop really effective? There may be a lack of clinical trials.
    Tests and scientific proofs on tumor research [Cell Sub-Journal] For the first time, a molecular map of small cell lung cancer was drawn, using single-cell RNA sequencing to reveal the behind-the-scenes of tumor metastasis-an unusual cell type.
    New crown epidemic [Science blockbuster] WHO Organize the establishment of a new team including Yang Yungui of the Chinese Academy of Sciences to restart research on the origin of the pandemic that may have come from laboratory leaks! Medical progress [Science hot discussion] There were only 17 women in 115 years! Why do men often sweep the Nobel Prize and women winners do so Less? Intelligent diagnosis [Research] "Artificial Intelligence + Biomedicine" applied to liver cancer with a high mortality rate is expected to revolutionize the diagnosis and treatment of cancer in the future! Disease prevention [Science] WHO initiates the development of a new "Global Roadmap" A low-cost five-in-one vaccine is expected to eliminate the bacterial meningitis epidemic in 2030.
    Intestinal flora [Nature Sub-Journal] Intestinal Warfare: Revealing how the human intestinal microbiota resists cholera bacteria.
    Professor Xu Chenming from the Obstetrics and Gynecology Hospital: Non-invasive prenatal screening has entered the era of clinical application of single gene diseases.
    Medical progress [Nature hot discussion] Why is the 2021 Nobel Prize not awarded to the COVID-19 vaccine that saves countless lives?
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.